Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 SEK | -3.59% | +9.34% | -57.96% |
Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.96% | 67.6M | |
+5.10% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.30% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.59% | 16.85B | |
+4.46% | 13.76B | |
+34.90% | 12.46B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Transcript : Oncopeptides AB, Q3 2022 Earnings Call, Nov 09, 2022